Therapeutic advances in women's cancers
Amy R Carroll1, Robert L Coleman, Anil K Sood
1Department of Gynecologic Oncology, M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Frontiers in Bioscience (Scholar Edition)
|January 4, 2011
Summary
New targeted drugs show promise for treating gynecologic malignancies, offering new hope beyond traditional cytotoxic therapy and surgery for these common women's cancers.
Area of Science:
- Oncology
- Molecular Biology
- Gynecologic Oncology
Background:
- Gynecologic malignancies remain a significant cause of cancer-related mortality in women annually.
- While cytotoxic therapy and surgery have improved outcomes, novel therapeutic strategies are needed.
- Advances in understanding cancer pathogenesis have identified key molecular pathways crucial for tumor survival.
Purpose of the Study:
- To review promising new biologically targeted drugs for gynecologic malignancies.
- To highlight therapeutic strategies targeting essential tumor survival pathways.
- To provide an overview of drugs currently in clinical testing for women's cancers.
Main Methods:
- Literature review of recent clinical trials and preclinical studies.
- Focus on drugs targeting angiogenesis, DNA repair, and apoptosis.
- Analysis of emerging therapeutic agents in gynecologic oncology.
Main Results:
- Several novel targeted therapies demonstrate potential in preclinical and early clinical studies.
- Drugs targeting angiogenesis, DNA repair, and apoptosis pathways are under active investigation.
- These agents represent a new frontier in treating gynecologic cancers.
Conclusions:
- Biologically targeted drugs offer a promising avenue for improving outcomes in gynecologic malignancies.
- Targeting specific molecular pathways may overcome limitations of conventional treatments.
- Continued research and clinical trials are essential to realize the full potential of these new therapies.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...